Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)

ClinicalTrials.gov ID: NCT00145327

Public ClinicalTrials.gov record NCT00145327. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 3-year, Double-blind Extension to CZOL446H2301 to Evaluate the Long-term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This extension study is designed to assess the long term safety and efficacy of zoledronic acid in postmenopausal women with osteoporosis who have participated in the CZOL446H2301 (NCT00049829): HORIZON Pivotal Fracture Trial. This extension study began after the 3-year core study ended. Baseline is the same as Year 3.

Study identification

NCT ID
NCT00145327
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis
Industry
Enrollment
2,456 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
68 Years to 90 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2005 (Type not available)
Primary completion
Nov 2009 (Actual)
Completion
Nov 2009 (Actual)
Last update posted
Jun 28, 2011

2005 – 2009

United States locations

U.S. sites
30
U.S. states
22
U.S. cities
29
Facility City State ZIP Site status
Southern Arizona VA Tucson Arizona 85723 —
University of Arkansas for Medical Science Little Rock Arkansas 72205 —
Osteoporosis Medical Center Beverly Hills California 90211 —
Osteoporosis Prevention Center San Diego California 92103 —
Diablo Clinical Research, Inc Walnut Creek California 94598 —
Colorado Center for Bone Research Lakewood Colorado 80227 —
CRIA Research Fort Lauderdale Florida 33334 —
Radiant Research Stuart Florida 34996 —
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409 —
United Osteoporosis Centers (UOC) Gainesville Georgia 30501 —
Northwestern University Center for Clinical Research Chicago Illinois 60611 —
School of Medicine Indianapolis Indiana 46202 —
Medical Specialist Clinical Research Center Munster Indiana 46321 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Maine Center for Osteoporosis Research and Education Bangor Maine 04401 —
Osteoporosis Clinical Trial Center Hagerstown Maryland 21740 —
Clinical Pharmacology Study Groups Worcester Massachusetts 01610 —
Washington University Center for Clinical Studies St Louis Missouri 62110 —
New Mexico Clinical Research and Osteoporosis Center Inc Albuquerque New Mexico 87106 —
Winthrop U Hospital Mineola New York 11501 —
Odyssey Research Services/CCRC Internal Medical Fargo North Dakota 58104 —
University of Cincinnati Bone Health and Osteoporosis Center Cincinnati Ohio 45219 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19131 —
University of Pittsburgh Pittsburgh Pennsylvania 15261 —
Radiant Research Wyomissing Pennsylvania 19610 —
Rhode Island Hospital, Endocrinology Clinical Research Unit Providence Rhode Island 02903 —
University of Tennessee Health Science Memphis Tennessee 38105 —
McGuire Veterans Affairs Medical Center Richmond Virginia 23249 —
VA Commonwealth University Richmond Virginia 23298 —
Puget Sound Osteoporosis Center Seattle Washington 98144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00145327, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2011 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00145327 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →